Spots Global Cancer Trial Database for Ixabepilone Administered as an Enteric Coated Formulation.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Ixabepilone Administered as an Enteric Coated Formulation.
Official Title: An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer.
Study ID: NCT00309049
Conditions
Study Description
Brief Summary: The purpose of this study is to determine the pharmacokinetics of oral Ixabepilone.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution, Washington, District of Columbia, United States
Local Institution, Detroit, Michigan, United States
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
